Article Listing - Hospira gains rights to commercialize Kiadis Pharma’s ATIR in Europe, Africa and Asia-Pacific

ANTIBIOTICS AND OTITIS MEDIA

4 May 1992

A meta-analysis of 10 studies has confirmed that antibiotics are effective as a short-term cure for effusive otitis media. The...

OTC LABELING "MISLEADS CONSUMERS"

4 May 1992

The US Food and Drug Administra-tion has relied too much on the pharmaceutical industry to monitor the safety of over-the-counter...

3rd HEP C VIRUS DISCOVERED

4 May 1992

Researchers at the Scottish Blood Transfusion Service, the University of Edinburgh and the Medical Research Council report discovery of a...

PAXIL, NOT AROPAX

4 May 1992

The US trade name for SmithKline Beecham's paroxetine is to be Paxil, and not Aropax. A New Drug Application for...

ORTHODOX AIDS VIEW CHALLENGED

4 May 1992

The belief that AIDS is not caused by HIV, first put forward by the scientist who mapped the genetic structure...

KEMRON COMES UNDER ATTACK

4 May 1992

The US National Institutes of Health's AIDS Research Advisory Committee (ARAC) has published a statement which concludes that the Kenya-developed...

LOREX' AMBIEN SET FOR US APPROVAL?

4 May 1992

Lorex Pharmaceuticals has received preliminary approval from the US Food and Drug Administration for Ambien (zolpidem tartrate) its non-benzodiazepine hypnotic...

S-P BACKs TOKYO INSTITUTE WITH $2.5m

4 May 1992

An endowment of $2.5 million has been established by Schering-Plough for the Bioscience and Biotechnology faculty of the Tokyo Institute...

SUCCESS IN A GLOBAL MARKETPLACE

4 May 1992

For a research-based pharmaceutical company to be successful, it needs to ensure that there is a seamless transition from the...

FRENCH HOMEOPATHIC DRUGS COMPETITION

4 May 1992

Competition in France between the two leading producers of homeopathic medicines, Boiron and Dolisos, has intensified, despite a 6.2 million...

Showing 94041-94050 of 95325 articles